Cabaletta Bio Shares Tick Up Ahead of June Data Investors Await
Cabaletta Bio shares rose to $3.92 in light premarket trading Monday, up from Friday’s $3.78 close. The company is scheduled to present at the Jefferies Global Healthcare Conference on June 3 and at EULAR in London on June 4. Cabaletta reported $116.6 million in cash at March’s end, plus $141 million raised in May. Its latest 10-Q still includes going-concern language and trial execution risks.